News Focus
News Focus
icon url

ziploc_1

05/28/25 10:23 AM

#436015 RE: louieblouie #436013

Louieblouie...In the days following the PDUFA meeting, the price of Amarin went briefly above $25/sh...(that was BEFORE the recent 20 to 1 reverse split of Amarin share price)....this means the equivalent price of Amarin today would be ~ $500/sh.

It demonstrates the potential of Lr-Et-EPA WITHOUT GENERIC COMPETITION in the U.S....(and with an active marketing program, which the advent of generic competition made unsustainable for Amarin)

Plus the fact that Lr-Et-EPA is a superior drug to Vascepa in dosage and effect.
icon url

lizzy241

05/28/25 11:54 AM

#436023 RE: louieblouie #436013

louie aka LB, I recall having the same sinking feelings. The 3/30/2020 Dueaster will forever be ingrained in my mind. It was lockdown day from covid and the day I moved to a new residence, downsized. As I watched the stock price plummet, I was totally baffled. Being new to biotech investing, I had NO idea patents could be invalidated. How silly of me, I froze, then asked my son to tell the movers to get everything in my house so I could find out what happened to AMRN. Before that fatal day, I had traded the stock for about 2 years prior and made some decent coin. But puff.
I recall a couple of years ago someone called into the Jim Cramer show 🤡 asking for his thoughts on Amarin, his response was "either it gets sold or goes out of business". It's not going out of business so I'm guessing it will be sold. Not that his remark will change my mind. I'm in it to win it...